Trial Profile
Remediation of schizophrenia sensory gating deficit with aripiprazole
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 10 Dec 2007 New trial record.